Antimicrobial activity of Mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa

Annals of Clinical Microbiology and Antimicrobials (2016)

Experimental treatment for dementia in end-stage Alzheimer’s disease: a case report

NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.

Genomic characterization and assessment of the virulence of the novel Paenibacillus sp. VT-400, a potentially pathogenic bacterium

Genomic characterization and assessment of the virulence and antibiotic resistance of the novel species Paenibacillus sp. strain VT-400, a potentially  pathogenic bacterium in the oral cavity of patients with hematological  malignancies

Gut pathogens (2016)

In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria.

Annals of Clinical Microbiology and Antimicrobials (2015)

Draft Genome Sequence of Acinetobacter sp. strain VT-511 Isolated from the Stomach of a Patient with Gastric Cancer

Genome announcements (2015)

Complete Genome Sequence of Paenibacillus sp. strain VT-400, Isolated from the Saliva of a Child with Acute Lymphoblastic Leukemia

Genome announcements (2015)

Complete genome sequence of Bacilli bacterium strain VT-13- 104 isolated from the intestine of a patient with duodenal cancer.

Genome announcements (2015)

DNase I Treatment Reduces GVHD in Mice

Biology of Blood and Marrow Transplant (2015)

Mul-1867, A Drug Candidate For Inhalation Therapy Of Pulmonary Exacerbations Caused By Burkholderia Cepacia Complex In Cystic Fibrosis And Copd Patients
Nanoglobular and Linear Antimicrobials Against Biofilms Formed by Burkholderia Cepacia Isolated From Cystic Fibrosis Patients.